Novel biomarkers for cholangiocarcinoma: how can it enhance diagnosis, prognostication, and investigational drugs? Part-1
Expert Opinion on Investigational Drugs | September 28, 2021 | Volume: 30 | Issue: 10 | Pages: 1047-1056
10.1080/13543784.2021.1985461
| PMID 34579607